← Eichor
Condition: Tuberculosis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Tuberculosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Population Pharmacokinetics of Anti-tuberculosis Drugs in Children With Tuberculosis
Phase N/A · 1 location(s) · Beijing Children's Hospital · NCT03625739Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin
Phase 1 · 1 location(s) · Brigham and Women's Hospital · NCT05069688Evaluation of IGRA, Symptoms and Chest Radiograph for Subclinical TB Detection in ESRD and KT
Phase N/A · 1 location(s) · Mahidol University · NCT06700876Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients
Phase N/A · 1 location(s) · University of Oxford · NCT05571735Identification of New Biological Markers for the Progression of Mycobacterium Abscessus-induced Lung Disease in Cystic F
Phase N/A · 1 location(s) · Ospedale San Raffaele · NCT06413459Integrating HIV Prevention With TB Household Contact Evaluation in Uganda
NA · 1 location(s) · University of Washington · NCT07119359Hotspots, Households and Hospitals: Enhanced Drug-resistant Tuberculosis Case Finding in Namibia
Phase N/A · 1 location(s) · University of Namibia · NCT05022238ID93+GLA-SE Vaccine Against Tuberculosis in Older Adults Aged 55-74
Phase 1 · 4 location(s) · Quratis Inc. · NCT06714513Clinical Trial to Evaluate the Efficacy and Safety of EEC for the Diagnosis of Mycobacterium Tuberculosis Infection in P
Phase 3 · 8 location(s) · Chengdu CoenBiotech Co., Ltd · NCT07152639Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis
Phase 2/Phase 3 · 6 location(s) · University of California, San Francisco · NCT06441006Safety of Administering Isoniazid to SLE Patients to Prevent TB
Phase 2/Phase 3 · 1 location(s) · Universitas Padjadjaran · NCT06618573Tuberculosis in Rural and Malnourished Populations
NA · 1 location(s) · University of Virginia · NCT06971952Rapid Research in Diagnostics Development for TB Network
NA · 16 location(s) · University of California, San Francisco · NCT0492395818F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis Patients
Phase N/A · 1 location(s) · Children's Hospital Medical Center, Cincinnati · NCT07077213Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin
Phase 2 · 8 location(s) · Kevin Winthrop · NCT05730283Adjunctive Doxycycline for Central Nervous System Tuberculosis
Phase 2 · 6 location(s) · National University Hospital, Singapore · NCT06446245The Safety, Completion Rate and Prevention Effect by Rifamycin-containing Regimens for Latent Tuberculosis Infection in
Phase 4 · 1 location(s) · National Taiwan University Hospital · NCT05588492Environmental Reservoirs of Non-tuberculous Mycobacteria in Cystic Fibrosis Households: A Case-control Study of Exposure
Phase N/A · 2 location(s) · Research Center Borstel · NCT07369414Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB
Phase 2 · 11 location(s) · University College, London · NCT06114628Novel Triple-dose Tuberculosis Retreatment Regimen
Phase 3 · 1 location(s) · Institute of Tropical Medicine, Belgium · NCT04260477ESAT6/CFP10 Skin Testing for TB Infection in Rheumatologic Patients
Phase N/A · 2 location(s) · Chinese University of Hong Kong · NCT06796647Diagnostic Utility of Mycobacterium Tuberculosis Cell-free DNA
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT06439810Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tube
Phase 3 · 5 location(s) · Huashan Hospital · NCT05081401Short Course Regimen in Low Risk Active Tuberculosis- a Multicenter, Randomized, Active-controlled, Trial
Phase 3 · 8 location(s) · Kaohsiung Veterans General Hospital. · NCT06727864Pragmatic Use of Next-generation Sequencing for Management of Drug-resistant Tuberculosis
NA · 1 location(s) · University of California, San Francisco · NCT05553236Precision Rifampin Trial for Personalized Dosing
Phase 1 · 1 location(s) · University of Virginia · NCT06318416Characterization of Tuberculosis Associated Lung Fibrosis and Respiratory Impairment, and Prevention Using Doxycycline
Phase 2 · 2 location(s) · Makerere University · NCT06477185Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)
NA · 2 location(s) · Johns Hopkins University · NCT07164742Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda
NA · 1 location(s) · Yale University · NCT05917210Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of M
Phase 2 · 11 location(s) · Janssen Research & Development, LLC · NCT02354014
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.